Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC

被引：2
|
作者：
Musick, K. [1 ]
Howard, J. [2 ]
Li, G. [3 ]
Vu, T. [4 ]
Korobko, D. [5 ]
Smilowski, M. [6 ]
Liu, L. [1 ]
Steeland, S. [1 ]
Noukens, J. [7 ]
Van Hoorick, B. [1 ]
Podhorna, J. [1 ]
Li, Y. [8 ]
Utsugisawa, K. [9 ]
Sacca, F. [10 ]
Wiendl, H. [11 ]
De Bleecker, J. [12 ]
Mantegazza, R. [13 ]
机构：
[1] Argenx, Ghent, Belgium
[2] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA
[3] Medsol Clin Res Ctr Inc, Port Charlotte, FL USA
[4] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA
[5] State Novosibirsk Reg Clin Hosp, State Budgetary Healthcare Inst Novosibirsk Reg, Novosibirsk, Russia
[6] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland
[7] Curare Consulting BV, Hamburg, Germany
[8] Cleveland Clin, Cleveland, OH USA
[9] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan
[10] Federico II Univ Naples, NRSO Dept, Naples, Italy
[11] Univ Munster, Dept Neurol, Munster, Germany
[12] Ghent Univ Hosp, Ghent, Belgium
[13] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy
来源：
NEUROMUSCULAR DISORDERS | 2023年 / 33卷
关键词：
D O I：
10.1016/j.nmd.2023.07.443
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P276
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [41] Long-term efficacy and safety of tacrolimus in young children with myasthenia gravis
    Zhang, Yan
    Zhang, Min
    Zhang, Linmei
    Zhou, Shuizhen
    Li, Wenhui
    JOURNAL OF CLINICAL NEUROSCIENCE, 2023, 116 : 93 - 98
  • [42] Long-Term Safety, Tolerability, And Efficacy of Efgartigimod In Patients With gMG: Final Analyses From The ADAPT plus Study
    Meisel, A.
    De Bleecker, J.
    Verschuuren, J.
    Bril, V.
    Vu, T.
    Karam, C.
    Peric, S.
    Murai, H.
    Beydoun, S.
    Pasnoor, M.
    Steeland, S.
    Van Hoorick, B.
    T'joen, C.
    Utsugisawa, K.
    Mantegazza, R.
    Howard, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 208 - 209
  • [43] Long-Term Safety Outcomes of Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis: A Pooled Analysis
    Vissing, John
    Grosskreutz, Julian
    Habib, Ali A.
    Utsugisawa, Kimiaki
    Vu, Tuan
    Grosskreutz, Julian
    Boehnlein, Marion
    Gayfieva, Maryam
    Greve, Bernhard
    Tarancon, Thais
    Woltering, Franz
    Il, Vera
    ANNALS OF NEUROLOGY, 2024, 96 : S265 - S265
  • [44] A Phase II Trial to Assess the Efficacy, Safety and Feasibility of 20 [percnt] Subcutaneous Immunoglobulin in Patients with Myasthenia Gravis Exacerbation - Interim Analysis of Efficacy
    Siddiqi, Zaeem
    Mallon, Ashley
    Blackmore, Derrick
    NEUROLOGY, 2016, 86
  • [45] Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
    Howard, James F., Jr.
    Karam, Chafic
    Yountz, Marcus
    O'Brien, Fanny L.
    Mozaffar, Tahseen
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (07): : 1398 - 1407
  • [46] LONG-TERM EFFICACY OF ECULIZUMAB IN REFRACTORY GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES
    Howard, James
    Karam, Chafic
    Yountz, Marcus
    O'Brien, Fanny
    Mozaffar, Tahseen
    MUSCLE & NERVE, 2019, 60 : S133 - S133
  • [47] Long-Term Efficacy and Safety of Low-Dose Rituximab in Patients with Refractory Myasthenia Gravis
    Ren, Jingru
    Wang, Jianchun
    Liu, Ran
    Jin, Yunyi
    Guo, Jing
    Yao, Yan
    Luo, Jingjing
    Hao, Hongjun
    Gao, Feng
    EUROPEAN NEUROLOGY, 2023, 86 (06) : 387 - 394
  • [48] Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
    Howard, James F. Jr Jr
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Perk, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    LANCET NEUROLOGY, 2021, 20 (07): : 526 - 536
  • [49] Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis
    Genge, Angela
    Leite, M. Isabel
    Bresch, Saskia
    Freimer, Miriam
    Hewamadduma, Channa
    Hussain, Yessar
    Maniaol, Angelina
    Mantegazza, Renato
    Smilowski, Marek
    Utsugisawa, Kimiaki
    Vu, Tuan
    Duda, Petra W.
    Boroojerdi, Babak
    Vanderkelen, Mark
    De la Borderie, Guillemette
    Bloemers, Jos
    Howard, James F., Jr.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [50] Long-term safety, efficacy & self-injection satisfaction with zilucoplan in myasthenia gravis: RAISE-XT interim analysis
    Farmakidis, C.
    Leite, M.
    Bresch, S.
    Freimer, M.
    Genge, A.
    Hewamadduma, C.
    Hussain, Y.
    Maniaol, A.
    Mantegazza, R.
    Smilowski, M.
    Utsugisawa, K.
    Vu, T.
    Duda, P.
    Boroojerdi, B.
    Vanderkelen, M.
    de la Borderie, G.
    Bloemers, J.
    Howard, J., Jr.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S178 - S178
12345